News from apexigen, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 17, 2015, 08:00 ET

Apexigen Presents Positive Data for APX005M in Podium Presentation at Immune Checkpoint Inhibitors (ICI) Europe

 Apexigen, Inc., a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the...

Nov 06, 2015, 07:30 ET

Apexigen Presents Preclinical Data from Novel Immuno-Oncology Candidate APX005M at SITC 2015 Meeting

 Apexigen, Inc., a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the...

Jun 16, 2015, 08:00 ET

Apexigen Doses First Patient in Phase 1 Clinical Trial of Its Immuno-oncology Therapeutic Antibody APX005M

 Apexigen, Inc., a biopharmaceutical company discovering and developing innovative antibody drugs for the treatment of cancer and other...

May 06, 2015, 08:30 ET

Apexigen Selected to Present at Cavendish Global Health Impact Forum

SAN CARLOS, Calif., May 6, 2015 /PRNewswire/-- Apexigen, Inc., a biopharmaceutical company discovering and developing innovative antibody...

Oct 15, 2014, 08:30 ET

Apexigen Strengthens its Management Team with Additions of Vice President, Clinical Development and Vice President, Finance

 Apexigen, Inc., a biopharmaceutical company discovering and developing innovative antibody drugs for the treatment of cancer and other...

Aug 06, 2013, 06:00 ET

Apexigen Secures $20 Million Series A1 Financing

Apexigen Inc., a biopharmaceutical company dedicated to discovering and developing innovative antibody-based drugs for the treatment of serious...

Nov 11, 2012, 17:00 ET

Apexigen Announces Initiation of Clinical Trials By Its Partner, Simcere Pharmaceutical Group

Apexigen, an emerging biopharmaceutical company dedicated to the discovery and development of best-in-class therapeutic monoclonal antibodies,...

Aug 15, 2012, 23:59 ET

Apexigen Announces the Filing of an IND by its Partner, 3SBio

 Apexigen, Inc., an emerging biopharmaceutical company focused on the discovery and development of monoclonal antibody therapeutics, announced...

Mar 06, 2012, 23:59 ET

Apexigen and Shanghai Duyiwei Biotechnology Co. Ltd Sign a License and Collaboration Agreement to Develop and Commercialize APX004

 Apexigen, Inc., a privately held biopharmaceutical company, and Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (GDBP), which is listed on...

Mar 11, 2011, 05:00 ET

Apexigen Announces the Filing by its Partner, Simcere Pharmaceutical Group, of First IND

Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its...

Dec 07, 2010, 05:00 ET

Apexigen, Inc. Announces Collaboration for Antibody Discovery

Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development,...